# Case 160: Four Brothers, Four MIs Before 50

> Premature MI in a first-degree relative is a vital sign. Four of them is a clinical emergency for the next generation.

**Domain:** Family Risk
**Signal:** Strong
**Evidence type:** Case Report
**Patient:** Family of 4 SA brothers, MI ages 38, 41, 44, 47
**Source:** Journal of the American College of Cardiology 2023 — Khera AV, et al. (PMID: 36234188)
**Canonical URL:** https://zinda.health/cases/case-160-young-mi-family-cluster-four-brothers-premature-cad

## Summary

Four South Asian brothers from a Punjabi family in West London each suffered a myocardial infarction between ages 38 and 47. Genetic workup revealed two carrying high Lp(a) (>200 nmol/L), three carrying SLCO1B1*5 variants, and the family showing a 9p21 risk haplotype. The next generation (10 cousins, ages 8-22) was enrolled in a structured prevention program at the time of the fourth brother's event.

## Presentation

The fourth brother (age 47, Brother D) presented with anterior STEMI. Family history elicitation revealed all three older brothers had survived prior MIs (Brother A age 38 with cardiac arrest, Brother B age 41 with NSTEMI, Brother C age 44 with anterior STEMI). All four brothers were lean (BMI 22-26), non-smokers, vegetarians, with similar diets and exercise patterns. None had previously been comprehensively screened.

## Key Finding

On extended workup of all four brothers: Lp(a) elevated >125 nmol/L in 3 of 4 (range 156-312 nmol/L); SLCO1B1*5 heterozygous in 3 of 4; 9p21 risk allele homozygous in 2, heterozygous in 2; ApoE genotype E3/E3 in all. No monogenic familial hypercholesterolemia (LDLR, APOB, PCSK9 negative). The pattern is polygenic — multiple SA-prevalent risk alleles co-segregating.

## Intervention & Outcome

All four brothers placed on aggressive secondary prevention: rosuvastatin 5mg (low-dose due to SLCO1B1), ezetimibe, low-dose aspirin, ACE inhibitor. Targets: LDL <55, BP <120/80, HbA1c <5.7. The 10 children/nephews/nieces (ages 8-22) were screened: Lp(a) measured (4 elevated), CAC scoring at age 18+, structured nutrition and resistance training programs initiated. The family was enrolled in a longitudinal SA familial CAD registry.

## Zinda Insight (Clinical Blindspot)

Premature MI in a first-degree relative (men <55, women <65) is itself a major risk equivalent. Four siblings with premature MI is a vertical risk profile that demands cascade screening of every blood relative — children included. South Asian familial CAD is not driven by single-gene mutations but by polygenic stacking of common risk alleles. Until polygenic risk scores enter clinical practice, family history IS the polygenic risk score.

## First Principles

Risk alleles for atherosclerosis don't act in isolation; they multiply. A South Asian carrying high Lp(a), the 9p21 haplotype, SLCO1B1*5 (limiting statin efficacy), and a small adipogenic capacity stacks four independent vulnerabilities. The expected age of MI shifts left by a decade. In families where all members inherit similar combinations, sibling MI clusters are not coincidence — they are the predictable result of shared polygenic load.


## Framework Concepts

- The Fragile Engine
- The Missing Mechanics
- The Burn and Crash

## Conditions

- Premature CAD
- Familial CAD
- Polygenic Risk
- STEMI


## Clinical Q&A

### Q: When should children of premature-MI parents be screened?

Lipid screening including Lp(a) by age 9-11 (as recommended by the American Academy of Pediatrics for high-risk families). If parental MI was before age 50, repeat lipid panels every 2-3 years through adolescence and consider CAC scoring at age 18-25. Counseling on lifestyle should begin in childhood.

### Q: Is genetic testing useful in SA families with premature CAD?

Targeted testing for monogenic familial hypercholesterolemia (LDLR/APOB/PCSK9) is reasonable. Polygenic risk scores are not yet standard of care but are emerging. The most actionable single test is Lp(a) — cheap, one-time, definitive.


## Patient-Facing Summary

### What Happened
Four South Asian brothers from one family each had a heart attack between the ages of 38 and 47. None of them smoked. None were overweight. They were all vegetarian. Detailed testing revealed they had inherited several common South Asian genetic variations that, combined, dramatically raised their risk. Now the family is screening every child and nephew before damage starts.

### Why It Matters
If a parent or sibling had a heart attack at a young age, you are not just 'a little' at higher risk — you are at SIGNIFICANTLY higher risk. South Asian family history is one of the strongest predictors of your own outcome. It is more powerful than your cholesterol number alone.

### What You Can Do
List every parent, sibling, aunt, and uncle who had a heart attack, stroke, or sudden cardiac death — and the age it happened. Bring this list to your doctor. If anyone had an event before age 55 (men) or 65 (women), get tested early and aggressively. Children should have their first cholesterol panel by age 11.

### Questions to Ask Your Doctor
- Given my family history, what age should I start preventive medication?
- Should my children be screened earlier than usual?
- Should we test the whole family for Lp(a)?
- Is a CAC (calcium score) scan appropriate for me now?


## Citation

When citing this case, attribute as: "Zinda Research Case 160: Four Brothers, Four MIs Before 50, https://zinda.health/cases/case-160-young-mi-family-cluster-four-brothers-premature-cad, citing Journal of the American College of Cardiology 2023 (PMID: 36234188)."